D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRSL
4251
Brightstar Lottery PLC
BRSL
$1.92B
| $469K | ﹤0.01% |
18,984
-500
| -3% | -$13.4K |
|
4252
Xencor
XNCR
$1.48B
| $468K | ﹤0.01% |
+17,559
| New | +$566K |
|
|
HMTV
4253
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $468K | ﹤0.01% |
102,331
+6,676
| +7% | +$40.2K |
|
4254
Alamo Group
ALG
$2B
| $467K | ﹤0.01% |
3,247
+1,507
| +87% | +$218K |
|
|
REV
4255
DELISTED
Revlon, Inc.
REV
| $466K | ﹤0.01% |
57,753
-76,699
| -57% | -$734K |
|
|
GBT
4256
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $464K | ﹤0.01% |
13,402
-13,421
| -50% | -$401K |
|
4257
Kadant
KAI
$3.72B
| $463K | ﹤0.01% |
2,384
-93
| -4% | -$19K |
|
4258
S&T Bancorp
STBA
$1.92B
| $463K | ﹤0.01% |
15,639
+261
| +2% | +$8.2K |
|
4259
Universal Logistics Holdings
ULH
$393M
| $462K | ﹤0.01% |
22,949
-7,705
| -25% | -$146K |
|
|
MORF
4260
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $461K | ﹤0.01% |
11,476
-14,300
| -55% | -$599K |
|
|
AGRX
4261
DELISTED
Agile Therapeutics
AGRX
| $460K | ﹤0.01% |
1,099
+18
| +2% | +$11.5K |
|
4262
PUT
Trip.com Group
TCOM
$28.5B
| $458K | ﹤0.01% |
19,800
-142,500
| -88% | -$3.59M |
|
|
RUTH
4263
CALL
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $458K | ﹤0.01% |
20,000
| – | – |
|
|
COOP
4264
PUT
DELISTED
Mr. Cooper
COOP
| $457K | ﹤0.01% |
10,000
| – | – |
|
4265
CALL
Sysco
SYY
$40.7B
| $457K | ﹤0.01% |
+5,600
| New | +$453K |
|
4266
PUT
Norfolk Southern
NSC
$76.1B
| $456K | ﹤0.01% |
1,600
-1,700
| -52% | -$468K |
|
|
SWAV
4267
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $456K | ﹤0.01% |
2,200
-20,000
| -90% | -$3.3M |
|
4268
CytomX Therapeutics
CTMX
$701M
| $454K | ﹤0.01% |
+169,951
| New | +$653K |
|
4269
Immuneering
IMRX
$274M
| $454K | ﹤0.01% |
+70,127
| New | +$674K |
|
4270
Tenaya Therapeutics
TNYA
$164M
| $454K | ﹤0.01% |
+38,516
| New | +$466K |
|
4271
Eos Energy Enterprises
EOSE
$1.22B
| $453K | ﹤0.01% |
108,372
+94,658
| +690% | +$390K |
|
4272
Myers Industries
MYE
$1.26B
| $453K | ﹤0.01% |
+20,989
| New | +$383K |
|
4273
National CineMedia
NCMI
$371M
| $451K | ﹤0.01% |
17,764
+6,077
| +52% | +$169K |
|
4274
Restaurant Brands International
QSR
$26B
| $451K | ﹤0.01% |
7,719
-164
| -2% | -$9.33K |
|
|
PLXP
4275
DELISTED
PLx Pharma Inc. Common Stock
PLXP
| $451K | ﹤0.01% |
+111,625
| New | +$612K |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.